OBX-115 Engineered TIL with Regulatable Membrane- Bound IL15: Translational Data from Patients with Advanced Melanoma

Time: 12:00 pm
day: Conference Day One CMC Track AM

Details:

• OBX-115 is a highly differentiated TIL cell therapy with optimized characteristics for response and persistence
• This data confirms successful platform validation, supporting the proposed OBX-115 mechanism of action
• ACZ dose-driven regulatable mbIL15 expression on OBX-115 enables elimination of IL2 from the regimen and the potential for a safer, more effective TIL cell therapy

Speakers:

Parameswaran Hari Parameswaran Hari, M.D., M.S., is Obsidian’s Chief Development Officer. Dr. Hari brings decades of experience designing, managing and leading complex cell and gene therapy clinical Read more